Stay updated on Nivolumab in Resectable NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.

Latest updates to the Nivolumab in Resectable NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedLocations section added with Maryland, New York, Washington, and Quebec sites; the older location blocks were removed and the page revision updated to v3.3.3.SummaryDifference0.4%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedTimestamp-related fields such as 'Last Update Posted (Estimated)' and recent dates (e.g., 2025-11-17, 2025-11) were updated. No changes were made to the study content, arms, or eligibility criteria.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study. Updated the revision tags to v3.3.2 and v3.2.0 in the Publications sections.SummaryDifference0.1%

- Check56 days agoChange DetectedRemoved the banner notice about a lapse in government funding from the page; the study details and supporting information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check70 days agoChange DetectedNo significant changes detected between the two screenshots; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check98 days agoChange DetectedAdded a government-status notice and a v3.2.0 revision; removed the v3.1.0 revision. The page now informs users about potential delays and where to check current operating status, and indicates the new version.SummaryDifference1%

Stay in the know with updates to Nivolumab in Resectable NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.